Get Published | Subscribe | About | Write for Our Blog    

News RSS Bioethics News.


AstraZeneca resumes Covid-19 vaccine trials in the U.K.

External Link - Source: STAT

“A United Kingdom-based Phase 2/3 study testing a Covid-19 vaccine being developed by AstraZeneca has been restarted… news comes four days after the disclosure that it had been paused because of a suspected serious adverse reaction.” AstraZeneca came into the news recently due to a pause in their clinical trial from suspected reactions in a participant. What does this restart mean for progress of a future vaccine?

This entry was posted in Clinical Ethics, Clinical Trials & Studies and tagged . Bookmark the permalink.